A-Kavach™ – The Biological  shield That Protects Your Joints From Arthritis

Arthritis is not just “wear and tear.” For decades, patients were told their cartilage simply eroded because of aging or excessive load. But modern joint biology tells a more complete story:

**Your knee is under continuous chemical attack.**

Inside an arthritic joint, destructive enzymes, inflammatory molecules, and oxidative stress work like microscopic knives, cutting through cartilage and accelerating its breakdown — often long before your X-ray shows severe change. That’s why some patients with only mild X-ray findings have significant pain, and some with advanced-looking X-rays have very little.

**A-Kavach™** is designed to interrupt that chemical attack — as the first step in a two-part biological strategy.

—

## Why “Wear and Tear” Alone Doesn’t Explain Arthritis

For years, osteoarthritis was treated as a purely mechanical problem — a hinge wearing down. But we now understand:

– Cartilage breakdown is driven substantially by biochemical inflammation
– Enzymes such as MMPs and ADAMTS, along with inflammatory cytokines, break down collagen and proteoglycans in cartilage
– This process can begin long before it’s visible on an X-ray
– Mechanical load is a contributing factor — but the chemical cascade is what drives ongoing destruction

A-Kavach™ is built specifically to interrupt that chemical cascade — before more cartilage is lost.

What Is A-Kavach™?

A-Kavach™ is an autologous (from your own blood) biological shield developed at the **Madras Joint Rejuvenation Centre (MJRC)**, Kasthuri Hospital, Chennai. It is concentrated from your own platelet-poor plasma and is rich in alpha-2 macroglobulin (A2M) — a naturally occurring protein that neutralizes the destructive enzymes driving cartilage breakdown.

**A-Kavach™ is the first step, injected before anything else, because its protective action needs to take effect immediately.** Once the joint’s chemical environment is no longer actively hostile, we follow with the **PRASAD™ Protocol** — our platelet-rich, stromal, and marrow-derived biologic combination — to work within a joint that is no longer under active biochemical attack.

*(You can read the full explanation of the PRASAD™ Protocol here →
A-Kavach™’s role, specifically:

1. Neutralizing destructive enzymes

A-Kavach™ binds and inactivates excess proteases and inflammatory molecules circulating in the joint — slowing the chemical erosion of cartilage.

2. Reducing the inflammatory load on the joint

By lowering the concentration of destructive molecules, A-Kavach™ helps create a less hostile environment for the joint tissues that remain.
3. Addressing joint pain generators

A significant share of arthritic pain comes from synovial inflammation, bone marrow lesions, and nerve sensitization within the joint — not from cartilage itself, which has no nerve supply. By calming the inflammatory drivers, A-Kavach™ can contribute to reducing this pain signal, though it works alongside, not in place of, a full biologic strategy.

—

Who Is A-Kavach™ For?

A-Kavach™ may be appropriate for patients who:

– Have early to moderate osteoarthritis
– Have pain that seems disproportionate to X-ray severity
– Want to explore joint preservation before considering knee replacement
– Have signs of active inflammation within the joint
– Are looking to maintain mobility and function over the coming years

Patients with metabolic syndrome, obesity, or chronic low-grade inflammation may benefit in particular, since these conditions tend to keep the joint’s chemical environment more hostile.

*(Candidacy is assessed individually — a consultation is the only way to know if A-Kavach™ and the PRASAD™ Protocol are appropriate for your joint.)*

Why Timing Matters

By the time advanced arthritis is visible on X-ray, a great deal of cartilage is already lost. But the chemical destruction driving that loss often begins years earlier. A-Kavach™ is designed to intervene while there is still cartilage worth protecting.

A-Kavach™ in Context

| Approach | What It Does | Limitations |
| Painkillers | Reduce pain sensation | Do not slow underlying joint damage |
| Steroid injections | Fast, short-term relief | Repeated use may accelerate cartilage loss |
| Physiotherapy | Improves joint mechanics and strength | Does not address the biochemical drivers of destruction |
| Knee replacement | Definitive solution for end-stage disease | Major surgery; not appropriate for early-to-moderate OA |
| **A-Kavach™ + PRASAD™** | Targets the chemical drivers of cartilage loss and supports a healthier joint environment | Does not regenerate cartilage — no established treatment does |

—

What A-Kavach™ Does Not Claim to Do

To be direct: **A-Kavach™ does not regenerate cartilage. No established treatment today reverses cartilage loss.** What it does is protect the cartilage you still have, by addressing the chemical destruction driving further loss — and prepare the joint for the regenerative work of the PRASAD™ Protocol that follows.

What Patients Commonly Report

Individual results vary, and outcomes should be discussed with your treating doctor. Patients who respond well to the A-Kavach™ + PRASAD™ approach commonly report improvements in pain, walking tolerance, and night-time comfort over the following weeks to months.

Take the First Step

Arthritis progression is not automatically inevitable — the chemical processes driving it can often be influenced, particularly when addressed early.

**A-Kavach™ is the shield. PRASAD™ is what follows once the joint is ready.**

To learn more or book a consultation:

📞 095661 43108
✉️ drvenkatjoints@gmail.com
🌐 drakvenkat.com/contact

*Dr. A.K. Venkatachalam, FRCS — Madras Joint Rejuvenation Centre, Kasthuri Hospital, West Tambaram, Chennai*